Urologic Survey (Functional Urology)

Re: Laparoscopic Sleeve Gastrectomy Effects on Overactive Bladder Symptoms


  • Lokman Irkilata

J Urol Surg 2015;2(3):158-158


Obesity increases the risk of several comorbidities. Though the relationship between a variety of urogenital complications and morbid obesity (MO) has been demonstrated, the information showing a relationship between overactive bladder (OAB) and MO is limited. Laparoscopic sleeve gastrectomy (LSG) is currently the most commonly chosen surgical procedure for obesity. Recently, Palleschi et al. assessed the prevalence of OAB in the MO population and the resolution of these symptoms after LSG. They included 120 patients (60 female-male) undergoing LSG in their study group. They created a control group of 120 patients (60 female-male) with the same criteria who were waiting for LSG. The patient group recorded a 3-day voiding diary (VD) and completed OAB short-form questionnaire (OABq-SF) 1 week before and 180 days after surgery. OAB diagnosis was present in 35% of the patient group and 28% of the control group. In the MO patient and control groups, OAB was found at higher rates in females than in males. In the patient group, a significant improvement was found by comparing OABq-SF scores and VD parameters before and after LSG. There was no change found in the OABq-SF scores and VD parameters in the control group. Treatment of obesity with LSG provided an improvement in OAB symptoms. When the increasing rate of bariatric surgery in our country in recent times is considered, this is a very good study showing both the relationship between MO and OAB, and the improvement in OAB symptoms with obesity treatment.